Seroprevalence of Anti-SARS-CoV-2 IgG Antibody in Healthcare Workers: A Report From Rafsanjan City

Author(s):
Mahnaz TashakoriMahnaz Tashakori1, Ahmad JamalizadehAhmad Jamalizadeh2, Mohsen Nejad-GhaderiMohsen Nejad-Ghaderi2, Maryam HadaviMaryam Hadavi3, Aliakbar Yousefi-AhmadipourAliakbar Yousefi-Ahmadipour1, fatemeh mohseni moghadamfatemeh mohseni moghadam1, Athareh SoresrafilAthareh Soresrafil1, mashayekhi mashayekhimashayekhi mashayekhi4,*
1Department of Laboratory Sciences, Faculty of Paramedicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
2Non-communicable Diseases Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
3Department of Anesthesiology, Paramedical School, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
4Immunology of Infectious Diseases Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
*Corresponding Author: Immunology of Infectious Diseases Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. Email: [email protected]

Journal of Inflammatory Diseases:Vol. 25, issue 4; 203-210
Published online:Mar 31, 2022
Article type:Research Article
How to Cite:Tashakori M, Jamalizadeh A, Nejad-Ghaderi M, Hadavi M, Yousefi-Ahmadipour A, et al. Seroprevalence of Anti-SARS-CoV-2 IgG Antibody in Healthcare Workers: A Report From Rafsanjan City. J Inflamm Dis. 2024;25(4):e156295. doi:

Abstract

Background: Healthcare workers (HCWs) have a high risk of catching SARS-CoV-2 infection. Seroprevalence studies can provide related data on HCWs with a history of infections. Despite numerous seroepidemiological reports of COVID-19 in different groups, there are no such reports for HCWs working in Rafsanjan City, Iran. This study aimed to determine the SARS-CoV-2 seroprevalence among HCWs. Methods: Blood samples were obtained from 295 participants, including healthcare personnel and administrative staff. The SARS-CoV-2 IgG antibody was measured by the ELISA method, and the obtained data were analyzed with the Chi-square test and logistic regression. A P<0.05 was considered statistically significant. Results: The previous exposure to COVID-19 was higher in HCWs than in administrative department staff. Fifteen out of 130 (11.5%) participants had experienced SARS-CoV-2 infection without any symptoms. The results of logistic regression indicated that traveling (OR: 018, 95% CI: 0.08–0.74, P=0.001), occupation (OR: 0.2, 95% CI: 0.01–0.94, P<0.05), history of respiratory problems (OR: 0.15, 95% CI: 0.01–1.94, P<0.05), and major clinical signs (OR: 8.09, 95% CI: 3.7-17.66, P<0.001) are important factors which affect SARS-CoV-2 IgG antibodies.  Conclusion: Our results indicated an occupational risk for SARS-CoV-2 infection among HCWs. Because some HCWs are asymptomatic, their communication, such as traveling, must be controlled, and it is necessary to ensure the safety of HCWs and reduce their transfer to the community and patients.

Copyright

© 2024, Journal of Inflammatory Diseases. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.

Similar Articles

17
Feb
2021

Prevalence of Anti-SARS-CoV-2 Antibody in Hospital Staff in Double-Center Setting: A Preliminary Report of a Cohort Study From Iran

Kamran Bagheri Lankarani,
Behnam Honarvar,
Navid Omidifar,
Majid Pakdin,
Mohsen Moghadami,
Mansoureh Shokripour
,et al.

Bagheri Lankarani K, Honarvar B, Omidifar N, Pakdin M, Moghadami M, et al. Prevalence of Anti-SARS-CoV-2 Antibody in Hospital Staff in Double-Center Setting: A Preliminary Report of a Cohort Study From Iran. Shiraz E-Med J. 2021;22(3):e112681. doi: https://doi.org/10.5812/semj.112681

28
May
2024
J Adv Immunopharmacol

Seroprevalence of Anti-SARS-CoV-2 Antibodies Among Asymptomatic Healthcare Workers of Dezful Ganjavian Hospital, Southwest Iran

Amir Mashayekhi,
Mehdi Bashirkhabaz,
Fatemeh Pourmotahari,
Rezvan Reyhani,
Sedigheh Alebakhit,
Ezatollah Ghasemi

Mashayekhi A, Bashirkhabaz M, Pourmotahari F, Reyhani R, Alebakhit S, et al. Seroprevalence of Anti-SARS-CoV-2 Antibodies Among Asymptomatic Healthcare Workers of Dezful Ganjavian Hospital, Southwest Iran. J Adv Immunopharmacol. 2024;4(1):e146101. doi: https://doi.org/10.5812/jai-146101

27
Jul
2022

SARS-CoV-2 Antibodies in the Public Hospital Staff: The Second Report of a Seroprevalence Cohort Study from Iran

Aida Amanat,
Kamran Bagheri Lankarani,
Behnam Honarvar,
Naeimehossadat Asmarian,
Mansoureh Shokripour,
Fatemeh Rafiee
,et al.

Amanat A, Bagheri Lankarani K, Honarvar B, Asmarian N, Shokripour M, et al. SARS-CoV-2 Antibodies in the Public Hospital Staff: The Second Report of a Seroprevalence Cohort Study from Iran. Shiraz E-Med J. 2022;23(9):e121681. doi: https://doi.org/10.5812/semj-121681

23
Aug
2022
Jundishapur J Microbiol

Seroprevalence of Anti-SARS-CoV-2 Antibodies in High-Risk Occupational and Low-Risk Groups in Southwestern Iran

Nasrin Aliabadi,
Nahid Heydari Marandi,
Marzieh Jamalidoust,
Zahra Ashkan,
Gholamreza Pouladfar,
Mazyar Ziyaeyan

Aliabadi N, Heydari Marandi N, Jamalidoust M, Ashkan Z, Pouladfar G, et al. Seroprevalence of Anti-SARS-CoV-2 Antibodies in High-Risk Occupational and Low-Risk Groups in Southwestern Iran. Jundishapur J Microbiol. 2022;15(7):e126975. doi: https://doi.org/10.5812/jjm-126975

5
Oct
2022
Arch Pediatr Infect Dis

Prevalence and Clinical Presentation of COVID 19 in Health Care Workers in Two Main Hospitals During the Pandemic in Shiraz, Iran

Marzieh Jamalidoust,
Zahra Ashkan,
Gholamreza Pouladfar,
Sadaf Asaei,
Nasrin Aliabadi,
Pejman Abbasi
,et al.

Jamalidoust M, Ashkan Z, Pouladfar G, Asaei S, Aliabadi N, et al. Prevalence and Clinical Presentation of COVID 19 in Health Care Workers in Two Main Hospitals During the Pandemic in Shiraz, Iran. Arch Pediatr Infect Dis. 2022;10(4):e121753. doi: https://doi.org/10.5812/pedinfect-121753

Download PDF1.12 MB
Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles